Design, synthesis and antitumor study of novel NO-type porphyrin–ferulic acid derivatives for chemotherapy and photodynamic therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design, synthesis and antitumor study of novel NO-type porphyrin–ferulic acid derivatives for chemotherapy and photodynamic therapy

Published:2024 Issue:26 Volume:48 Page:11783-11793
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Liu Zhenhua¹²,Yang Lingyan¹²,Tian Zejie¹²,Li Hui¹²,Shi Lei¹²,Tang Chen¹²,Guo Yu¹²^ORCID,He Jun³,Liu Yunmei¹²^ORCID

Affiliation:

1. Institute of Pharmacy & Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang City, Hunan Province, 421001, P. R. China

2. Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, 28 Western Changshen Road, Hengyang City, Hunan Province, 421001, P. R. China

3. Institute of Chemistry & Chemical Engineering, University of South China, Hengyang City, Hunan Province, 421001, P. R. China

Abstract

NO-type porphyrin-ferulic acid derivatives were obtained by combining NO donor, ferulic acid, and porphyrin. It can realize the combined treatment of phototherapy and chemotherapy and effectively kill cancer cells.

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/NJ/D4NJ01134A

Reference47 articles.

1. Fighting Cancer with Corroles

2. Recent Advances in Upconversion Nanoparticles-Based Multifunctional Nanocomposites for Combined Cancer Therapy

3. Functionalized Holmium-Doped Hollow Silica Nanospheres for Combined Sonodynamic and Hypoxia-Activated Therapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP